HAMP and metabolic dysfunction-associated steatotic liver disease: Further evidence linking central obesity with deranged ferritin and hepcidin in the context of NAFLD is shown by Pan et al. [16], particularly for female patients, as well as by the Fatty Liver in Obesity (FLiO) study, with a model of glucose, serum ferritin, and alanine aminotransferase having an Area Under the Curve of 0.83 in 112 obese and overweight patients [78].